BioSpace News Archive

Medcura, Inc., a commercial-stage medical device company, announced that it has been awarded a $2M follow-on grant to expand its implantable products program based, in part, on successful results under a previous grant from the U.S. Military.

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that the Company will participate in two upcoming investor conferences in March: Cowen & Co. 41 st Annual Health Care Conference on Wednesday, March 3, 2021:

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it will report its financial results for the year ended December 31, 2020, on Thursday, March 4, 2021, before the market opens.

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced the appointment of Dagmar Rosa-Bjorkeson to its Board of Directors as of April 1, 2021.

Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, announced that Jounce management will present at several upcoming investor conferences

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:00 a.m. ET on Thursday, March 4, 2021, to discuss its fourth quarter and full year 2020 financial results and provide a business update.

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced that the U.S. Patent and Trademark Office has granted the Company Patent No. 10,607,802 B2, titled “Three-Dimensional Beam Forming X-Ray Source.”

Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) , has been granted Investigational Device Exemption (IDE) authorization by the United States Food and Drug Administration (FDA) to conduct a usability trial to demonstrate the safety and efficacy of DIMI for performing hemodialysis in the home environment.

Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer will be participating in a fireside chat at the 41 st Annual Cowen Health Care Conference taking place March 1-4, 2021.

Meridian Bioscience, Inc., a provider of diagnostic testing solutions and life science raw materials, provided a further update on its application for Emergency Use Authorization with the U.S. Food and Drug Administration for the SARS-CoV-2 molecular diagnostic test on its Revogene® platform.